Insights into the Relationship between Periodontitis and Systemic Sclerosis Based on the New Periodontitis Classification (2018): A Cross-Sectional Study
- PMID: 38473012
- PMCID: PMC10931108
- DOI: 10.3390/diagnostics14050540
Insights into the Relationship between Periodontitis and Systemic Sclerosis Based on the New Periodontitis Classification (2018): A Cross-Sectional Study
Abstract
(1) Background: This study aimed to assess the periodontitis burden in systemic sclerosis patients and the possible association between them, and the degree to which some potential risk factors and two potential diagnostic biomarkers may account for this association. (2) Methods: This cross-sectional study included a test group (systemic sclerosis patients) and a control group (non-systemic sclerosis patients). Both groups benefited from medical, periodontal examination and saliva sampling to determine the salivary flow rate and two inflammatory biomarkers (calprotectin, psoriasin). A systemic sclerosis severity scale was established. (3) Results: In the studied groups, comparable periodontitis rates of 88.68% and 85.85%, respectively, were identified. There were no significant differences in the severity of periodontitis among different systemic sclerosis severity, or in the positivity for anti-centromere and anti-SCL70 antibodies. Musculoskeletal lesions were significantly more common in stage III/IV periodontitis (n = 33, 86.84%) than in those in stage I/II (n = 1, 100%, and n = 3, 37.5%, respectively) (p = 0.007). Comparable levels of the inflammatory mediators were displayed by the two groups. There were no significant differences in calprotectin and psoriasin levels between diffuse and limited forms of systemic sclerosis. (4) Conclusions: Within the limitations of the current study, no associations between systemic sclerosis and periodontitis, or between their risk factors, could be proven.
Keywords: biomarker; inflammation; periodontitis; systemic scleroderma.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Serum Inflammatory and Prooxidant Marker Levels in Different Periodontal Disease Stages.Healthcare (Basel). 2021 Aug 20;9(8):1070. doi: 10.3390/healthcare9081070. Healthcare (Basel). 2021. PMID: 34442206 Free PMC article.
-
Periodontitis Burden in Diffuse Versus Limited Systemic Sclerosis Subtypes: A Pilot Study.Curr Health Sci J. 2023 Apr-Jun;49(2):280-287. doi: 10.12865/CHSJ.49.02.280. Epub 2023 Jun 30. Curr Health Sci J. 2023. PMID: 37779832 Free PMC article.
-
Association of salivary lactate dehydrogenase level with systemic inflammation in a Japanese population.J Periodontal Res. 2018 Aug;53(4):487-494. doi: 10.1111/jre.12537. Epub 2018 Feb 15. J Periodontal Res. 2018. PMID: 29446092
-
Macrophage activating factor: A potential biomarker of periodontal health status.Arch Oral Biol. 2016 Oct;70:94-99. doi: 10.1016/j.archoralbio.2016.06.010. Epub 2016 Jun 9. Arch Oral Biol. 2016. PMID: 27341461 Review.
-
The potential impact of salivary peptides in periodontitis.Crit Rev Clin Lab Sci. 2021 Nov;58(7):479-492. doi: 10.1080/10408363.2021.1907298. Epub 2021 Apr 13. Crit Rev Clin Lab Sci. 2021. PMID: 33849374 Review.
Cited by
-
Exploring Periodontal Conditions, Salivary Markers, and Systemic Inflammation in Patients with Cardiovascular Diseases.Biomedicines. 2024 Jun 17;12(6):1341. doi: 10.3390/biomedicines12061341. Biomedicines. 2024. PMID: 38927548 Free PMC article.
-
Evaluation of oral health in 148 patients with systemic sclerosis-data from a prospective interdisciplinary monocentric cohort.Rheumatol Int. 2024 Aug;44(8):1567-1573. doi: 10.1007/s00296-024-05635-z. Epub 2024 Jun 14. Rheumatol Int. 2024. PMID: 38874787 Free PMC article.
References
-
- Lescoat A., Huang S., Carreira P.E., Siegert E., de Vries-Bouwstra J., Distler J.H.W., Smith V., Del Galdo F., Anic B., Damjanov N., et al. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients with Systemic Sclerosis Sine Scleroderma: Data from the International EUSTAR Database. JAMA Dermatol. 2023;159:837–847. doi: 10.1001/jamadermatol.2023.1729. - DOI - PMC - PubMed
-
- Ciurea A., Rednic N.V., Soancă A., Micu I.C., Stanomir A., Oneț D., Șurlin P., Filipescu I., Roman A., Stratul Ș.I., et al. Current Perspectives on Periodontitis in Systemic Sclerosis: Associative Relationships, Pathogenic Links, and Best Practices. Diagnostics. 2023;13:841. doi: 10.3390/diagnostics13050841. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials